Suppr超能文献

相似文献

3
Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.
Rev Neurol (Paris). 2012 Dec;168(12):910-8. doi: 10.1016/j.neurol.2011.11.008. Epub 2012 Apr 30.
4
Early onset facioscapulohumeral dystrophy - a systematic review using individual patient data.
Neuromuscul Disord. 2017 Dec;27(12):1077-1083. doi: 10.1016/j.nmd.2017.09.007. Epub 2017 Sep 21.
6
Molecular diagnosis of facioscapulohumeral muscular dystrophy.
Expert Rev Mol Diagn. 2002 Mar;2(2):160-71. doi: 10.1586/14737159.2.2.160.
7
Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort.
Muscle Nerve. 2022 Apr;65(4):415-421. doi: 10.1002/mus.27493. Epub 2022 Jan 25.
8
An integrated approach in a case of facioscapulohumeral dystrophy.
BMC Musculoskelet Disord. 2014 May 15;15:155. doi: 10.1186/1471-2474-15-155.
9
The French National Registry of patients with Facioscapulohumeral muscular dystrophy.
Orphanet J Rare Dis. 2018 Dec 4;13(1):218. doi: 10.1186/s13023-018-0960-x.
10
Combined treatment with intravitreal bevacizumab and laser photocoagulation for exudative maculopathy in facioscapulohumeral muscular dystrophy.
Ophthalmic Genet. 2017 Sep-Oct;38(5):490-493. doi: 10.1080/13816810.2017.1279183. Epub 2017 Jan 25.

引用本文的文献

3
Muscular Dystrophies.
Adv Exp Med Biol. 2025;1478:245-284. doi: 10.1007/978-3-031-88361-3_11.
4
5
Current landscape for the management of facioscapulohumeral muscular dystrophy and emerging treatment modalities: A literature review.
AIMS Neurosci. 2025 Jun 25;12(2):291-311. doi: 10.3934/Neuroscience.2025016. eCollection 2025.
6
Advanced Heart Failure Therapies in Neuromuscular Diseases.
Curr Treat Options Cardiovasc Med. 2024 Aug;26(8):255-270. doi: 10.1007/s11936-024-01046-2. Epub 2024 Jun 25.
7
Hereditary Neuromuscular Disorders in Reproductive Medicine.
Genes (Basel). 2024 Oct 30;15(11):1409. doi: 10.3390/genes15111409.
9
Muscular dystrophy patients show low exercise-induced blood flow in muscles with normal strength.
Ann Clin Transl Neurol. 2024 Nov;11(11):2866-2876. doi: 10.1002/acn3.52194. Epub 2024 Sep 9.
10
French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD).
J Neurol. 2024 Sep;271(9):5778-5803. doi: 10.1007/s00415-024-12538-3. Epub 2024 Jul 2.

本文引用的文献

3
Facioscapulohumeral dystrophy: the path to consensus on pathophysiology.
Skelet Muscle. 2014 Jun 10;4:12. doi: 10.1186/2044-5040-4-12. eCollection 2014.
4
Risk of functional impairment in Facioscapulohumeral muscular dystrophy.
Muscle Nerve. 2014 Apr;49(4):520-7. doi: 10.1002/mus.23949. Epub 2014 Feb 10.
7
Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011.
Rev Neurol (Paris). 2012 Dec;168(12):910-8. doi: 10.1016/j.neurol.2011.11.008. Epub 2012 Apr 30.
9
Mutation spectrum and phenotypic manifestation in FSHD Greek patients.
Neuromuscul Disord. 2012 Apr;22(4):339-49. doi: 10.1016/j.nmd.2011.11.001. Epub 2012 Feb 21.
10
Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
PLoS Genet. 2010 Oct 28;6(10):e1001181. doi: 10.1371/journal.pgen.1001181.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验